Clinical Trials Market Highlights, Future Insights, Key Companies Updates, Share Analysis, Global Si

Market Highlights:

Clinical trial is a research study which involve people (healthy volunteers or patients) to test the safety and efficacy of a new treatment or medicine. In healthcare industry clinical trials are performed for medicine, medical devices which includes hearing aid and surgical procedure.

The market for global clinical trial market is estimated to grow at an approximate CAGR of 5.7% from 2017 to 2023.

The key factors driving the clinical trial industry includes rising prevalence of diseases, high R&D expenditure of the pharmaceutical industry, and growth of new treatments such as personalized medicine is supporting to grow the market. However, factors such as lack of skilled workforce clinical research, lower healthcare reimbursement in the developing countries and stringent regulations for patient enrollment, hinder the market growth.

Browse Report Details and Full TOC Exclusively @ https://www.marketresearchfuture.com/reports/clinical-trials-market-7787

Key Players:

• Charles River Laboratories
• Paraxel International Corporation
• Quintiles IMS
• ICON plc
• SGS SA
• Eli Lilly and Company
• Novo Nordisk A/S
• Clinipace
• Laboratory Corporation of America
• Pfizer

Segmentation:

• The global clinical trials market is segmented on the basis of phase, study design, indication and end users.
• On the basis of the phase, the market is categorized into phase I, phase II, phase III, and phase IV.
• On the basis of study design, the global clinical trials market is segmented into interventional, observational and expanded access.
• On the basis of indication, the global clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, central nervous system (CNS) condition, diabetes, obesity, cardiovascular and others.
• On the basis of the end-user, the market is segmented into dental hospitals & clinics, dental institutes and dental academic and research institutes.

Regional Analysis:

The Americas dominate the Global Clinical Trial Market owing to the presence of major pharmaceutical and biotech companies with R&D units in America and increasing patient population suffering from cardiac problem boost the clinical trial market in this region. Moreover, rising healthcare expenditure and presence of developed economies like U.S. and Canada fuels the market growth.

Europe is second in the global clinical trial market owing to increasing government support, rising clinical trail facilities both in private and government sector increases the clinical trial market in Europe.

Asia-Pacific region is the fastest growing market owing to the presence of developing economies, a growing healthcare sector and standard regulations related to healthcare industry promotes the manufactures to establish R&D unit in this region which drives the market with the region. The Middle East & Africa has the least share in the global clinical trial market owing to the presence of poor economies and stringent government policies, especially in the African region.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com